More funding, scientific insights and clinical advances have started to drive progress in this challenging disease, and researchers see potential for immunotherapy to revolutionize its future.
Nicole Fawcett is the manager of cancer communication for the University of Michigan Rogel Cancer Center, overseeing media relations, marketing, web, internal communication, social media and publications for the center’s research and clinical enterprises. She leads a team of four communicators who produce targeted, innovative communication to meet the Cancer Center’s goals. Nicole joined Michigan Medicine in 2003. Prior to that, she was at the Detroit News and at a startup web-based community for people with disabilities.
Patients feel providers do not adequately address concerns about the cost of cancer treatment, which can heighten anxiety during an already stressful time.
A new study helps set standards for RNA sequencing, improving standard practice and laying the foundation to move the field forward.
Surveys of patients and their surgeons showed genetic testing rates ranged from 26 to 72 percent, depending on the surgeon.
New research explains why stem cells become resistant to cancer treatment and opens a clever new way to go after them.
Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.